GlassScriptPhysician profile
Tara Stock
NPI 1639193568
$3,223.82
in general payments reported to CMS, 2019-2025
34 companies · $98.21 in 2025
The $98.21 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $995 · 2021: $921 · 2022: $171 · 2023: $357 · 2024: $15.22 · 2025: $98.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $470.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $476.70 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $390.85 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $352.11 | 2019-2023 | Jardiance, Glyxambi, Tradjenta |
| Glaxosmithkline, LLC. | $244.71 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $243.62 | 2019-2025 | Ubrelvy, Qulipta |
| Amarin Pharma, INC. | $206.90 | 2019-2021 | |
| Pfizer INC. | $163.98 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $151.41 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.61 | 2019-2021 | |
| Esperion Therapeutics, INC. | $105.00 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.69 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.13 | 2021-2023 | |
| Allergan, INC. | $57.69 | 2020 | |
| Horizon Therapeutics Plc | $53.58 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $48.93 | 2021-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $48.78 | 2019-2023 | Immunocap |
| Radius Health, INC. | $35.54 | 2020 | |
| Antares Pharma, INC. | $34.76 | 2020-2021 | |
| Kvk-Tech, INC. | $33.03 | 2019-2020 | |
| Exact Sciences Corporation | $30.50 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $29.79 | 2019 | |
| Vivus LLC | $29.77 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $29.34 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.90 | 2019 | |
| Abbott Laboratories | $24.00 | 2025 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $19.88 | 2023 | Aptima, Thinprep 2000 Processor |
| Sanofi Pasteur INC. | $17.63 | 2019 | |
| Eisai INC. | $17.05 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.25 | 2019 | |
| Lilly USA, LLC | $15.85 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.82 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $14.57 | 2019 | |
| Orthofix Medical, INC. | $13.45 | 2020-2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Stock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.